Publications in collaboration with researchers from Instituto de Investigación Sanitaria Gregorio Marañón (13)

2022

  1. Comparison of a polypharmacy-based scale with Charlson comorbidity index to predict 6-month mortality in chronic complex patients after an ED visit

    British Journal of Clinical Pharmacology, Vol. 88, Núm. 4, pp. 1795-1803

  2. Mobile Health Apps Providing Information on Drugs for Adult Emergency Care: Systematic Search on App Stores and Content Analysis

    JMIR mHealth and uHealth, Vol. 10, Núm. 4, pp. e29985

  3. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2020

  1. Promoting clinical pharmacy services through advanced medication review in the emergency department

    European Journal of Hospital Pharmacy , Vol. 27, Núm. 2, pp. 73-77

2019

  1. Drug safety surveillance within a strategy for the management of non-chemotherapy drug-induced neutropenia

    International Journal of Clinical Pharmacy, Vol. 41, Núm. 5, pp. 1143-1147

2018

  1. Twelve weeks of ombitasvir/paritaprevir/r and dasabuvir without ribavirin is effective and safe in the treatment of patients with HCV genotype 1b infection and compensated cirrhosis: results from a real-world cohort study

    Expert Opinion on Drug Safety, Vol. 17, Núm. 3, pp. 235-241

2017

  1. Análisis de los resultados económicos y en salud de un programa dirigido a la reducción de hemorragia en pacientes con síndrome coronario agudo

    Revista Espanola de Cardiologia, Vol. 70, Núm. 10, pp. 825-831

  2. Improving pharmacotherapy outcomes in patients with hepatitis C virus infection treated with direct-acting antivirals: The GRUviC project

    International Journal of Clinical Practice, Vol. 71, Núm. 8

  3. Iniciativas para conseguir una atención excelente en el síndrome coronario agudo. Respuesta

    Revista Espanola de Cardiologia

2016

  1. Decreased INR after acenocoumarol, ombitasvir/paritaprevir/ritonavir and dasabuvir co-administration

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 4, pp. 444-446

  2. Optimisation of antithrombotic therapy in patients with acute coronary syndrome to reduce bleeding episodes

    International Journal of Clinical Practice, Vol. 70, Núm. 2, pp. 156-162

  3. The challenges of the loading dose

    Drugs and Therapy Perspectives, Vol. 32, Núm. 10, pp. 447-448

2014

  1. Effectiveness of a pilot intervention to reduce abciximab-related bleeding in patients with acute coronary syndromes

    International Journal of Clinical Pharmacy, Vol. 36, Núm. 4, pp. 821-826